These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33724963)

  • 1. Adverse Discharge Outcomes Associated With the Medicare Hospital Readmissions Reduction Program Among Commercially Insured Adults.
    Alfandre D; Bipin Gandhi A; Onukwugha E
    J Healthc Qual; 2022 Jan-Feb 01; 44(1):1-10. PubMed ID: 33724963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia.
    Khera R; Dharmarajan K; Wang Y; Lin Z; Bernheim SM; Wang Y; Normand ST; Krumholz HM
    JAMA Netw Open; 2018 Sep; 1(5):e182777. PubMed ID: 30646181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.
    Buhr RG; Jackson NJ; Kominski GF; Dubinett SM; Mangione CM; Ong MK
    J Gen Intern Med; 2020 Dec; 35(12):3581-3590. PubMed ID: 32556878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.
    Gupta A; Allen LA; Bhatt DL; Cox M; DeVore AD; Heidenreich PA; Hernandez AF; Peterson ED; Matsouaka RA; Yancy CW; Fonarow GC
    JAMA Cardiol; 2018 Jan; 3(1):44-53. PubMed ID: 29128869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
    Wadhera RK; Joynt Maddox KE; Wasfy JH; Haneuse S; Shen C; Yeh RW
    JAMA; 2018 Dec; 320(24):2542-2552. PubMed ID: 30575880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Hospital Readmissions From the Emergency Department After Implementation of Medicare's Hospital Readmissions Reduction Program.
    Hsuan C; Carr BG; Hsia RY; Hoffman GJ
    JAMA Netw Open; 2020 May; 3(5):e203857. PubMed ID: 32356883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.
    Desai NR; Ross JS; Kwon JY; Herrin J; Dharmarajan K; Bernheim SM; Krumholz HM; Horwitz LI
    JAMA; 2016 Dec; 316(24):2647-2656. PubMed ID: 28027367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program.
    Lu CH; Clark CM; Tober R; Allen M; Gibson W; Bednarczyk EM; Daly CJ; Jacobs DM
    BMC Health Serv Res; 2021 Apr; 21(1):386. PubMed ID: 33902569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program.
    Ramaswamy A; Marchese M; Cole AP; Harmouch S; Friedlander D; Weissman JS; Lipsitz SR; Haider AH; Kibel AS; Schoenfeld AJ; Trinh QD
    JAMA Netw Open; 2019 May; 2(5):e194634. PubMed ID: 31150074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.
    Puebla Neira DA; Hsu ES; Kuo YF; Ottenbacher KJ; Sharma G
    Am J Respir Crit Care Med; 2021 Feb; 203(4):437-446. PubMed ID: 32871097
    [No Abstract]   [Full Text] [Related]  

  • 11. Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program.
    Sabbatini AK; Joynt-Maddox KE; Liao JM; Basu A; Parrish C; Kreuter W; Wright B
    JAMA Netw Open; 2022 Nov; 5(11):e2242587. PubMed ID: 36394872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California.
    Zingmond DS; Liang LJ; Parikh P; Escarce JJ
    Health Serv Res; 2018 Dec; 53(6):4403-4415. PubMed ID: 29740816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program.
    Huckfeldt P; Escarce J; Sood N; Yang Z; Popescu I; Nuckols T
    JAMA Netw Open; 2019 Mar; 2(3):e190634. PubMed ID: 30874780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational study assessing changes in timing of readmissions around postdischarge day 30 associated with the introduction of the Hospital Readmissions Reduction Program.
    Nathan AS; Martinez JR; Giri J; Navathe AS
    BMJ Qual Saf; 2021 Jun; 30(6):493-499. PubMed ID: 32694145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.
    Samsky MD; Ambrosy AP; Youngson E; Liang L; Kaul P; Hernandez AF; Peterson ED; McAlister FA
    JAMA Cardiol; 2019 May; 4(5):444-453. PubMed ID: 30969316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis.
    Wadhera RK; Joynt Maddox KE; Kazi DS; Shen C; Yeh RW
    BMJ; 2019 Aug; 366():l4563. PubMed ID: 31405902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes to Racial Disparities in Readmission Rates After Medicare's Hospital Readmissions Reduction Program Within Safety-Net and Non-Safety-Net Hospitals.
    Chaiyachati KH; Qi M; Werner RM
    JAMA Netw Open; 2018 Nov; 1(7):e184154. PubMed ID: 30646342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in 30- and 90-Day Readmission Rates for Heart Failure.
    Khan MS; Sreenivasan J; Lateef N; Abougergi MS; Greene SJ; Ahmad T; Anker SD; Fonarow GC; Butler J
    Circ Heart Fail; 2021 Apr; 14(4):e008335. PubMed ID: 33866827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Have 30-Day Readmission Penalties Affected Racial Disparities in Readmissions?: an Analysis from 2007 to 2014 in Five US States.
    Kaplan CM; Thompson MP; Waters TM
    J Gen Intern Med; 2019 Jun; 34(6):878-883. PubMed ID: 30737680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program.
    Li BY; Urish KL; Jacobs BL; He C; Borza T; Qin Y; Min HS; Dupree JM; Ellimoottil C; Hollenbeck BK; Lavieri MS; Helm JE; Skolarus TA
    JAMA Netw Open; 2019 Nov; 2(11):e1916008. PubMed ID: 31755949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.